[1] Huang D Q,Terrault N A,Tacke F, et al.Global epidemiology of cirrhosis-aetiology,trends and predictions[J].Nat Rev Gastroenterol Hepatol, 2023,20(6):388-398. [2] Asrani S K,Devarbhavi H,Eaton J, et al.Burden of liver diseases in the world[J].J Hepatol, 2019 ,70(1):151-171. [3] de Mattos? Z,Simonetto D A,Terra C, et al.Albumin administration in patients with cirrhosis:current role and novel perspectives[J].World J Gastroenterol, 2022,28(33):4773-4786. [4] Gairing S J,Schleicher E M,Galle P R, et al.Prediction and prevention of the first episode of overt hepatic encephalopathy in patients with cirrhosis[J].Hepatol Commun, 2023,7(4):e0096. [5] Jones B I,Jenkins C A,Murphy D, et al.Predicting hepatic encephalopathy in patients with cirrhosis: a UK population-based study and validation of risk scores[J].Hepatol Commun, 2023 ,7(11):e0307. [6] Tapper E B,Parikh N D,Sengupta N, et al.A risk score to predict the development of hepatic encephalopathy in a population-based cohort of patients with cirrhosis[J].Hepatology, 2018 ,68(4):1498-1507. [7] Labenz C,Toenges G,Schattenberg J M, et al.Outcome prediction of covert hepatic encephalopathy in liver cirrhosis:comparison of four testing strategies[J].Clin Transl Gastroenterol, 2020,11(6):e00172. [8] Wang J,Deng M J,Shi P M, et al.Covert hepatic encephalopathy is associated with aggressive disease progression and poor survival in patients with cirrhosis[J].J Dig Dis, 2023 ,24(12):681-690. [9] Balachandran V P,Gonen M,Smith J J, et al.Nomograms in oncology:more than meets the eye[J].Lancet Oncol, 2015,16(4):e173-180. [10] Ferenci P, Lockwood A, Mullen K, et al. Heptic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998[J].Hepatology, 2002,35(3):716-721. [11] Zeng X,Li X X,Shi P M, et al.Utility of the EncephalApp Stroop Test for covert hepatic encephalopathy screening in Chinese cirrhotic patients[J].J Gastroenterol Hepatol, 2019 ,34(10):1843-1850. [12] Butterworth R F.Ammonia removal by metabolic scavengers for the prevention and treatment of hepatic encephalopathy in cirrhosis[J].Drugs R D, 2021,21(2):123-132. [13] Won S M,Oh K K,Gupta H, et al.The link between gut microbiota and hepatic encephalopathy[J].Int J Mol Sci, 2022,23(16):8999. [14] Liu R,Ahluwalia V,Kang J D, et al.Effect of increasing age on brain dysfunction in cirrhosis[J].Hepatol Commun, 2018,3(1):63-73. [15] Tzanoulinou S,García-Mompó C,Riccio O,et al.Neuroligin-2 expression in the prefrontal cortex is involved in attention deficits induced by peripubertal stress[J].Neuropsychopharmacology, 2016,41(3):751-761. [16] Jepsen P,Watson H,Andersen P K, et al.Diabetes as a risk factor for hepatic encephalopathy in cirrhosis patients[J].J Hepatol, 2015,63(5):1133-1138. [17] Cheon S Y,Song J.The association between hepatic encephalopathy and diabetic encephalopathy:the brain-liver axis[J].Int J Mol Sci, 2021,22(1):463. [18] Louissaint J,Deutsch-Link S,Tapper E B.Changing epidemiology of cirrhosis and hepatic encephalopathy[J].Clin Gastroenterol Hepatol, 2022,20(8S):S1-S8. [19] Ebadi M,Bhanji R A,Mazurak V C, et al.Sarcopenia in cirrhosis:from pathogenesis to interventions[J].J Gastroenterol, 2019,54(10):845-859. [20] Miwa T,Hanai T,Nishimura K,et al.Handgrip strength stratifies the risk of covert and overt hepatic encephalopathy in patients with cirrhosis[J].JPEN J Parenter Enteral Nutr, 2022,46(4):858-866. [21] Romeiro F G,Augusti L.Nutritional assessment in cirrhotic patients with hepatic encephalopathy[J].World J Hepatol, 2015,7(30):2940-2954. [22] Vidal-Cevallos P,Chávez-Tapia N C,Uribe M.Current approaches to hepatic encephalopathy[J].Ann Hepatol, 2022,27(6):100757. [23] Is B,Bombassaro I Z,Tovo C V, et al.Albumin in the management of hepatic encephalopathy:a systematic review and meta-analysis[J].Ann Hepatol, 2021,26:100541. [24] Bai Z,Bernardi M,Yoshida E M, et al.Albumin infusion may decrease the incidence and severity of overt hepatic encephalopathy in liver cirrhosis[J].Aging(Albany NY), 2019,11(19):8502-8525. [25] Artigas A,Wernerman J,Arroyo V, et al.Role of albumin in diseases associated with severe systemic inflammation:pathophysiologic and clinical evidence in sepsis and in decompensated cirrhosis[J].J Crit Care, 2016,33:62-70. [26] Duah A,Agyei-Nkansah A,Osei-Poku F, et al.The prevalence,predictors,and in-hospital mortality of hepatic encephalopathy in patients with liver cirrhosis admitted at St Dominic Hospital in Akwatia,Ghana[J].Can J Gastroenterol Hepatol, 2020,2020:8816522. [27] Wang X,Zhao M,Zhang C, et al.Establishment and clinical application of the nomogram related to risk or prognosis of hepatocellular carcinoma:a review[J].J Hepatocell Carcinoma, 2023,10:1389-1398. |